| Reduced Risk Status: |
|
| IPM Compatibility: |
|
| Reasons for need: |
|
| Requesting State(s): |
IT:Ken Samoil, MUF* ;
|
| PCR Use Pattern: |
|
| EPA Default Residue Trials: |
10-5
|
| IR-4 Residue Trial Plan: |
10-5
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
IR-4 STUDY FOR THIS IS UNDER PR# 13067. PROTOCOL FOR DEVELOPING ADDITIONAL DATA TO MEET CODEX STANDARDS AND ATTAIN A CODEX MRL. TO BE FUNDED THROUGH THE MINOR USE FOUNDATION. RESIDUE STUDY TO BE CONDUCTED IN THE US.: 03/22; SYNGENTA DOES NOT SUPPORT THIS STUDY AT THIS TIME, THE PROPOSED MUF STUDY WILL NOT BE CONDUCTED IN 2022; SYNGENTA WILL NOT SUPPORT THIS REQUEST:06/22
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|